Yew Bio-Pharm Group, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2018. For the quarter, the company reported total revenues were $14,820,368 against $15,604,376 a year ago. Income from operations was $2,066,257 against $10,289,748 a year ago. Income before provision for income taxes was $1,613,188 against $10,255,513 a year ago. Net income was $1,613,188 against $10,254,909 a year ago. Diluted net income per common share was $0.03 against $0.19 a year ago. For the six months, the company reported total revenues were $17,851,506 against $23,479,840 a year ago. Income from operations was $2,285,680 against $10,511,325 a year ago. Income before provision for income taxes was $1,762,194 against $10,425,417 a year ago. Net income was $1,762,194 against $10,424,813 a year ago. Diluted net income per common share was $0.03 against $0.19 a year ago. Net cash provided by operating activities was $25,359,440 against $7,635 a year ago. Prepayments made to related party for purchase of yew forest assets was $372,098. Purchase of land use rights and yew forest assets of $23,681,125 against $679,387 a year ago.